Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Poloxamer 188

EU orphan designation number: EU/3/13/1112   
Active ingredient: Poloxamer 188
Indication: Treatment of sickle cell disease
Sponsor: Theradex (Europe) Ltd.
7 Pelham Court, Broadfield, Crawley, West Sussex RH11 9SH, United Kingdom

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/03/2013 Centralised Orphan - Designation EMA/OD/162/12 (2013)1606 of 12/03/2013